dadstimeon Posted January 10, 2007 Share Posted January 10, 2007 http://today.reuters.com/news/articlein ... URGENT.XML Jan 10 (Reuters) - Cell Therapeutics Inc. (CTIC.O: Quote, Profile , Research) (CTIC.MI: Quote, Profile , Research) said it filed for a special protocol assessment with the U.S. Food and Drug Administration for the design of its late-stage trial of Xyotax for women with advanced lung cancer. The trial will focus exclusively on women with normal estrogen levels, the subset where Xyotax demonstrated the greatest survival advantage, the company said in a statement. (Reporting by Shikhar Balwani in Bangalore) Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.